GO
Loading...

Myriad Genetics Inc

More

  • NEW YORK, July 17- Fed Chair Janet Yellen may have surprised the markets this week by noting that valuations in some parts of the U.S. stock market look stretched but mutual fund managers mostly greeted her comments with a shrug.

  • US STOCKS-Profit-taking drags Wall Street lower Tuesday, 11 Mar 2014 | 4:53 PM ET

    *Men's Wearhouse to acquire Jos. A. Bank Clothiers. Shares of retailers American Eagle and Urban Outfitters fell sharply after disappointing outlooks. They're just taking some money off the table, "said Frank Lesh, futures analyst and broker at FuturePath Trading LLC in Chicago.

  • *J.C. Penney jumps after Citi upgrade. *Copper prices fall to lowest since July 2010. "When you get a slow data week, markets tend to get a little jittery and slow," said Quincy Krosby, market strategist at Prudential Financial in Newark, New Jersey.

  • Midday movers: McDonald's, Senomyx, CBS & More Tuesday, 11 Mar 2014 | 12:49 PM ET
    A McDonald's restaurant is seen on November 14, 2013 in Miami, Florida.

    Some of Tuesday's midday movers:

  • US STOCKS-Wall Street little changed, near record highs Tuesday, 11 Mar 2014 | 10:59 AM ET

    *J.C. Penney jumps after Citi upgrade. *Urban Outfitters tumbles after warning. NEW YORK, March 11- U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued.

  • *J.C. Penney jumps after Citi upgrade. *Myriad Genetics falls after court motion denied. NEW YORK, March 11- U.S. stocks were set for a flat open on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and amid investor caution as tensions in Ukraine continued.

  • March 11- Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.

  • US STOCKS-Futures little changed as Ukraine eyed Tuesday, 11 Mar 2014 | 8:12 AM ET

    *J.C. Penny jumps after Citi upgrade. *Myriad Genetics falls after court motion denied. NEW YORK, March 11- U.S. stock index futures were little changed on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and as tensions in Ukraine tempered investor appetite for risk-taking.

  • US court denies Myriad Genetics' motion to block rival Tuesday, 11 Mar 2014 | 7:05 AM ET

    March 11- Diagnostics company Myriad Genetics Inc said a U.S. court denied a motion that would have stopped rival Ambry Genetics Corp from selling a similar version of Myriad's cancer test. The company had filed a complaint against Ambry in the U.S. District Court of Utah last July, alleging that Ambry's tests infringed some of its patents.

  • Early movers: MRK, TWX, UA, SNE, GOOG, BWLD & more Wednesday, 5 Feb 2014 | 7:34 AM ET
    Traders on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Midday movers: Twitter, Crocs, Walt Disney & More Monday, 30 Dec 2013 | 11:30 AM ET

    Some of Monday's midday movers.

  • Midday movers: Disney, Imax, Groupon & more Tuesday, 3 Dec 2013 | 1:00 PM ET

    Tuesday's midday movers:

  • After-hours buzz: Zynga, Cree, Brocade & more Tuesday, 13 Aug 2013 | 5:14 PM ET

    Check out which companies are making headlines after the bell Tuesday:

  • Retail sales to take pulse of the US consumer Monday, 12 Aug 2013 | 8:53 PM ET

    Tuesday’s retail sales should be an important check up on consumers and could show they are picking up their pace of spending.

  • Genome Research Benefits Growing, Getting Cheaper Sunday, 16 Jun 2013 | 10:05 AM ET

    Biotech and drug companies say the benefits of genome research are on the way, and just as importantly, advances are pushing the technology toward affordability.

  • SCOTUS: Human Genes Can't Be Patented     Thursday, 13 Jun 2013 | 7:10 PM ET

    The Supreme Court unanimously ruled that human genes cannot be patented, with CNBC's Bertha Coombs; David Resnick, Nixon Peabody LLP; Mitch Epner, Wilk Auslander Counsel; and Rich Lowry, National Review.

  • High Court's Ruling on DNA Could Boost Biotech Thursday, 13 Jun 2013 | 4:33 PM ET
    Justice Clarence Thomas

    A unanimous Supreme Court decision barred patents on naturally occurring DNA, but analysts said the ruling did little harm to biotech companies.

  • Myriad Hits Historic High     Thursday, 13 Jun 2013 | 3:42 PM ET

    CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.

  • Myriad Gets Partial Win In Ruling     Thursday, 13 Jun 2013 | 2:36 PM ET

    The Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test. CNBC's Bertha Coombs reports.

  • Biotech Check Amid SCOTUS Ruling     Thursday, 13 Jun 2013 | 1:25 PM ET

    A check on biotech stocks after the Supreme Court justices say naturally occurring human genes cannot be patented, with CNBC's Seema Mody.